Prevention of heart failure in the elderly: When, where and how to begin?

Heart Failure Reviews

Volumn 17, Issue 4-5, 2012, Pages 531-544

  Jugdutt, Bodh I ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aging; Heart failure; Markers; Prevention strategies; Telomere length

Indexed keywords

BIOLOGICAL MARKER; TELOMERASE;

AGED; AGING; CALORIC RESTRICTION; CARDIOVASCULAR RISK; CHILDHOOD; COMORBIDITY; CORONARY ARTERY DISEASE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIET; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; EUROPE; EXERCISE; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEART FAILURE; HEREDITY; HUMAN; HYPERTENSION; LIFESTYLE; PATHOPHYSIOLOGY; REVIEW; SMOKING CESSATION; TELOMERE; TELOMERE HOMEOSTASIS; UNITED STATES;

AGED; AGING; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; MALE; RISK FACTORS; TELOMERASE; TELOMERE;

EID: 84862674729     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-012-9299-x     Document Type: Review

References (148)

1. Centers for Disease Control and Prevention (2003) Public health and aging: trends in aging: United States and worldwide. MMRW Morb Mortal Wkly Rep 52:101-106. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5206a2.htm. Accessed 18 Aug 2011
2. He W, Sengupta M, Velkoff VA, DeBarros KA (2005) 65+ in the United States: 2005. Current Population Reports, P23-209. Government Printing Office, Washington, DC. Available at: http://www.census.gov/prod/2006pubs/p23-209.pdf. Accessed 18 Aug 2011
3. WB Kannel AJ Belanger 1991 Epidemiology of heart failure Am Heart J 121 951 957 2000773 1:STN:280:DyaK3M7lslOktA%3D%3D
4. D Lloyd-Jones RJ Adams TM Brown, et al. 2010 Heart disease and stroke statistics-2010 update: a report from the American Heart Association Circulation 121 e46 e215 20019324
5. SA Hunt WT Abraham MH Chin, et al. 2009 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation Circulation 119 e391 e479 19324966
6. H Johansen B Strauss MO Arnold G Moe P Liu 2003 On the rise: the current and projected future burden of congestive heart failure hospitalization in Canada Can J Cardiol 19 430 435 12704491
7. MO Arnold P Liu C Demers, et al. 2006 Canadian cardiovascular society consensus conference recommendations on heart failure 2006: diagnosis and treatment Can J Cardiol 22 23 45 16450016
8. A Jelani BI Jugdutt 2010 STEMI and heart failure in the elderly: role of adverse remodeling Heart Fail Rev 15 513 521 20549342
9. BI Jugdutt 2010 Aging and heart failure: changing demographics and implications for therapy in the elderly Heart Fail Rev 15 401 405 20364319
10. BI Jugdutt 2010 Heart failure in the elderly: advances and challenges Expert Rev Cardiovasc Ther 8 695 715 20450303
11. Jugdutt BI (2011) Biology of aging and heart failure management. In: Proceedings of the international academy of cardiology 16th world congress on heart disease annual scientific sessions 2011. Medimond, Bologne, Italy (in press)
12. JB O'Connell 2000 The economic burden of heart failure Clin Cardiol 23 Suppl III 6 103
13. Committee on the Future Health Care Workforce for Older Americans, Board of Health Care Services (2008) Retooling for an aging America: building the health care workforce. National Academies Press, Washington, DC. Available at: http://www.iom.edu/Reports/2008/Retooling-for-an-Aging-America-Building-the- Health-Care-Workforce.aspx. Accessed 18 Aug 2011
14. LW Stevenson 2011 Projecting heart failure into bankruptcy in 2012? Am Heart J 161 1007 1011 21641344
15. Lakatta EG, Gerstenblith G, Weisfeldt ML (1997) The aging heart: structure, function, and disease. In: Braunwald E (ed) Heart disease. Saunders, Philadelphia, pp 1687-1700
16. EG Lakatta 2003 Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I Circulation 107 139 146 12515756
17. EG Lakatta 2003 Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II Circulation 107 346 354 12538439
18. EG Lakatta M Wang SS Najjar 2009 Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels Med Clin North Am 93 583 604 19427493 1:CAS:528:DC%2BD1MXotFSqu78%3D
19. DM Lloyd-Jones MG Larson EP Leip, et al. 2002 Lifetime risk for developing congestive heart failure: the Framingham Heart Study Circulation 106 3068 3072 12473553
20. BI Jugdutt 2010 Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly Clin Interv Aging 5 403 416 21152242 1:CAS:528:DC%2BC3MXhsFei
21. RJ Goldberg D McCormick JH Gurwitz, et al. 1998 Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995) Am J Cardiol 82 1311 1317 9856911 1:STN:280:DyaK1M%2Fnt1Ogsw%3D%3D
22. S Yusuf S Hawken S Ounpuu for the INTERHEART Study Investigators, et al. 2004 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 937 952 15364185
23. WB Kannel 1990 Contribution of the Framingham Study to preventive cardiology J Am Coll Cardiol 15 206 211 2136875 1:STN:280:DyaK3c7htVOgtA%3D%3D
24. WB Kannel TR Dawber A Kagan N Revotskie J Stokes III 1961 Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study Ann Intern Med 55 33 50 13751193 1:STN:280: DyaF3c%2FntV2gsA%3D%3D
25. WB Kannel 2011 Sixty years of preventive cardiology: a Framingham perspective Clin Cardiol 34 342 343 21660990
26. DM Lloyd-Jones MG Larson A Beiser D Levy 1999 Lifetime risk of developing coronary artery disease Lancet 353 89 92 10023892 1:STN:280: DyaK1M7ks1CqtQ%3D%3D
27. DM Lloyd-Jones BH Nam RB D'Agostino Sr, et al. 2004 Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. A prospective study of parents and offspring JAMA 291 2204 2211 15138242 1:CAS:528:DC%2BD2cXktVGitLg%3D
28. DM Lloyd-Jones EP Leip MG Larson, et al. 2006 Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 791 798 16461820
29. DF Terry MJ Pencina RS Vasan, et al. 2005 Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants J Am Geriatr Soc 53 1944 1950 16274376
30. TR Dawber FE Moore Jr GV Mann 1957 Coronary heart disease in the Framingham Study Am J Public Health 47 4 24 1:STN:280:DyaG2s%2FlslKlsA%3D%3D
31. TR Dawber WB Kannel 1966 The Framingham Study: an epidemiological approach to coronary heart disease Circulation 34 553 555 5921755 1:STN:280:DyaF2s%2Fit1Cktw%3D%3D
32. SM Grundy 2002 Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) final report Circulation 106 3143 3421
33. PWF Wilson RB D'Agostino D Levy, et al. 1998 Prediction of coronary heart disease using risk factor categories Circulation 97 1837 1847 9603539 1:STN:280:DyaK1c3msVOjsA%3D%3D
34. SC Smith J Allen SN Blair, et al. 2006 AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update Circulation 113 2363 2372 16702489
35. RB D'Agostino RS Vasan MJ Pencina, et al. 2008 General cardiovascular risk profile for use in primary care. The Framingham Heart Study Circulation 117 743 753 18212285
36. PM Ridker JE Buring N Rifai NR Cook 2007 Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score JAMA 297 611 619 17299196 1:CAS:528:DC%2BD2sXhslCqtLk%3D
37. AP DeFilippis MJ Blaha CE Ndumele, et al. 2011 The association of Framingham and Reynolds risk scores with incidence and progression of coronary artery calcification in MESA (multi-ethnic study of atherosclerosis) J Am Coll Cardiol 58 2076 2083 22051329
38. PM Ridker NP Paynter N Rifai JM Gaziano NR Cook 2008 C-reactive protein and parental history improve global cardiovascular risk prediction. The Reynolds risk score for men Circulation 118 2243 2251 18997194 1:CAS:528: DC%2BD1cXhtlyks7bE
39. G Alberti P Zimmet J Shaw for the IDF Epidemiology Task Force Consensus Group 2005 The metabolic-syndrome-a new worldwide definition Lancet 366 1059 1062 16182882
40. AS Go GM Chertow D Fan CE McCulloch C Hsu 2004 Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization New Engl J Med 352 1296 1305
41. J Genest R McPherson J Frohlich, et al. 2009 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations Can J Cardiol 25 567 579 19812802 1:CAS:528:DC%2BD1MXhtlynsLvF
42. K Nasir ED Michos JA Rumberger, et al. 2004 Coronary artery calcification and family history of premature coronary heart disease. Sibling history is more strongly associated than parental history Circulation 110 2150 2156 15466626
43. S Mora LR Yanek TF Moy D Fallin LC Becker DM Becker 2005 Interaction of body mass index and Framingham risk score in predicting incident coronary disease in families Circulation 111 1871 1876 15837938
44. C Baigent A Keech PM Kearney for the Cholesterol Treatment Trialists' (CTT) Collaborators, et al. 2005 Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins Lancet 366 1267 1278 16214597 1:CAS:528: DC%2BD2MXhtVOlu7fM
45. PM Ridker E Danielson FAH Fonseca for the JUPITER Study Group, et al. 2008 Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein New Engl J Med 359 2195 2207 18997196 1:CAS:528: DC%2BD1cXhtl2gurnL
46. 100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women JAMA 294 326 333 16030277 1:CAS:528:DC%2BD2MXmtlGks78%3D
47. HC Wijeysundera M Machado F Farahati, et al. 2010 Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005 JAMA 303 1841 1847 20460623 1:CAS:528:DC%2BC3cXmtVOksbs%3D
48. B Zethelius L Berglund J Sundström, et al. 2008 Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2107 2116 18480203 1:CAS:528:DC%2BD1cXlvFCrsrw%3D
49. O Melander C Newton-Cheh P Almgren, et al. 2009 Novel and conventional biomarkers for prediction of incident cardiovascular events in the community JAMA 302 49 57 19567439 1:CAS:528:DC%2BD1MXotFKns7o%3D
50. LB Daniels GA Laughlin P Clopton, et al. 2008 Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study J Am Coll Cardiol 52 450 459 18672166 1:CAS:528:DC%2BD1cXpt1GrsL8%3D
51. CR deFilippi RH Christenson JS Gottdiener, et al. 2010 Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing J Am Coll Cardiol 55 441 450 20117457 1:CAS:528:DC%2BC3cXivVaqt74%3D
52. JL Januzzi Jr S Rehman AA Mohammed, et al. 2011 Use of amino-terminal pro-B natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol 58 1881 1889 22018299 1:CAS:528:DC%2BC3MXhsFOjtLzF
53. J Sundström E Ingelsson L Berglund, et al. 2009 Cardiac troponin-I and risk of heart failure: a community-based cohort study Eur Heart J 30 773 781 19264749
54. CR deFilippi JA de Lemos RH Christenson, et al. 2011 Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults JAMA 304 2494 2502
55. MG Shlipak LF Fried M Cushman, et al. 2005 Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors JAMA 293 1737 1745 15827312 1:CAS:528:DC%2BD2MXjtlWmtbo%3D
56. Petretta M, Daniele S, Acampa W et al (2011) Prognostic value of coronary artery calcium score and coronary CT angiography in patients with intermediate risk of coronary artery disease. Int J Cardiovasc Imaging. doi: 10.1007/s10554-011-9948-5
57. JE van Velzen FR de Graaf JW Jukema, et al. 2011 Comparison of the relation between the calcium score and plaque characteristics in patients with acute coronary syndrome versus patients with stable coronary artery disease, assessed by computed tomography angiography and virtual histology intravascular ultrasound Am J Cardiol 108 658 664 21684509
58. EK Kerut 2011 Coronary risk assessment and arterial age calculation using coronary artery calcium scoring and the Framingham risk score Echocardiography 28 686 693 21676014
59. G Güder J Bauersachs S Frantz D Weismann, et al. 2007 Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure Circulation 115 1754 1761 17372171
60. DW Kitzman WC Little PH Brubaker RT Anderson, et al. 2002 Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure JAMA 288 2144 2150 12413374
61. AS Maisel J McCord RM Nowak, et al. 2003 Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the breathing not properly multinational study J Am Coll Cardiol 41 2010 2017 12798574
62. AS Maisel JE Hollander D Guss, et al. 2004 Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath J Am Coll Cardiol 44 1328 1333 15364340
63. CR Benedict DH Weiner DE Johnstone, et al. 1993 Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the studies of left ventricular dysfunction (SOLVD) registry J Am Coll Cardiol 22 Suppl A 146A 153A 8376686 1:STN:280: DyaK3szovV2quw%3D%3D
64. WS Aronow JL Fleg CJ Pepine, et al. 2011 ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension J Am Soc Hypertens 5 259 352 21771565
65. KP Alexander LK Newby CP Cannon, et al. 2007 Acute coronary care in the elderly, part I. Non-ST-segment-elevation acute coronary syndromes. A scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 115 2549 2569 17502590
66. KP Alexander LK Newby PW Armstrong, et al. 2007 American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 115 2570 2589 17502591
67. M Jessup WT Abraham DE Casey, et al. 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines Circulation 119 1977 2016 19324967
68. International Diabetes Federation (2006) The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/MetS-def- update2006.pdf
69. CL Ogden MD Carroll LR Curtin, et al. 2006 Prevalence of overweight and obesity in the United States: 1999-2004 JAMA 295 1549 1555 16595758 1:CAS:528:DC%2BD28Xjt12itrk%3D
70. KM Narayan JP Boyle TJ Thompson, et al. 2003 Lifetime risk for diabetes mellitus in the United States JAMA 290 1884 1890 14532317 1:CAS:528: DC%2BD3sXotVWnsr4%3D
71. AK Gupta B Dahlof J Dobson, et al. 2008 Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the anglo-scandinavian cardiac outcomes trial-blood pressure lowering arm and the relative influence of antihypertensive medication Diabetes Care 31 982 988 18235048 1:CAS:528:DC%2BD1cXmsFGrtLY%3D
72. R Cooper-DeHoff JD Cohen GL Bakris, et al. 2006 Predictions of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril study (INVEST) Am J Cardiol 98 890 894 16996868 1:CAS:528:DC%2BD28XpvFemsLY%3D
73. AG Bertoni WG Hundley MW Massing, et al. 2004 Heart failure prevalence, incidence, and mortality in the elderly with diabetes Diabetes Care 27 699 703 14988288
74. S Yusuf KK Teo for the ONTARGET Investigators, et al. 2008 Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 1547 1559 18378520 1:CAS:528:DC%2BD1cXksF2isLs%3D
75. C Held HC Gerstein S Yusuf, et al. 2007 Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk Circulation 115 1371 1375 17339550 1:CAS:528:DC%2BD2sXislaisbw%3D
76. M Brownlee 2005 The pathobiology of diabetic complications. A unifying mechanism Diabetes 54 1615 1625 15919781 1:CAS:528:DC%2BD2MXltVaisbk%3D
77. A Ceriello 2005 Postprandial hyperglycemia and diabetes complications. Is it time to treat? Diabetes 54 1 7 15616004 1:CAS:528:DC%2BD2MXhtVWjtbc%3D
78. P Gaede H Lund-Andersen HH Parving O Pedersen 2008 Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 580 591 18256393 1:CAS:528:DC%2BD1cXhs1entLc%3D
79. M Deedwania Kosiborod E Barrett, et al. 2008 Hyperglycemia and acute coronary syndrome. A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, physical activity, and metabolism Circulation 117 1610 1619
80. WB Kannel RD Abbott DD Savage PM McNamara 1983 Coronary heart disease and atrial fibrillation: the Framingham Study Am Heart J 106 389 396 6869222 1:STN:280:DyaL3s3lt12jug%3D%3D
81. CD Furberg BM Psaty TA Manolio JM Gardin VE Smith PM Rautaharju 1994 Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study) Am J Cardiol 74 236 241 8037127 1:STN:280:DyaK2czhtFaiuw%3D%3D
82. DL Dries DV Exner BJ Gersh, et al. 1998 Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction J Am Coll Cardiol 32 695 703 9741514 1:STN:280:DyaK1cvht1Gntw%3D%3D
83. V Fuster LE Ryden DS Cannon for the Writing Committee Members, et al. 2006 ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 e257 e354 16908781
84. J Friberg H Scharling N Gadsbøll GB Jensen 2003 Sex-specific increase in the prevalence of atrial fibrillation (the Copenhagen City Heart Study) Am J Cardiol 92 1419 1423 14675577
85. B Ruo AM Capra NG Jensvold, et al. 2004 Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the epidemiology, practice, outcomes, and costs of heart failure (EPOCH) study J Am Coll Cardiol 43 429 435 15013126
86. WS Aronow M Banach 2009 Atrial fibrillation: the new epidemic of the aging world J Atr Fibrillation 1 337 361
87. WA Wattigney GA Mensah JB Croft 2003 Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention Circulation 108 711 716 12885749
88. D Mozaffarian CD Furberg BM Psaty, et al. 2008 Physical activity and incidence of atrial fibrillation in older adults: the Cardiovascular Health Study Circulation 118 800 807 18678768
89. AB Curtis BJ Bersh SD Corley, et al. 2005 Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Am Heart J 149 645 659 15990747
90. CB Harley 1991 Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256 271 282 1722017 1:CAS:528:DyaK38Xls1SisQ%3D%3D
91. H Vaziri W Dragowska RC Allsopp, et al. 1994 Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age Proc Natl Acad Sci USA 91 9857 9860 7937905 1:CAS:528:DyaK2cXmsFahurk%3D
92. MA Blasco 2005 Telomeres and human disease: ageing, cancer and beyond Nat Rev Genet 6 611 622 16136653 1:CAS:528:DC%2BD2MXntFeqtbw%3D
93. K Takubo N Izumiyama-Shimomura N Honma, et al. 2002 Telomere lengths are characteristic in each human individual Exp Gerontol 37 523 531 11830355 1:CAS:528:DC%2BD38XhtVKktLo%3D
94. PE Slagboom S Droog DI Boomsma 1994 Genetic determination of telomere size in humans: a twin study of three age groups Am J Hum Genet 55 876 882 7977349 1:STN:280:DyaK2M%2Fmsl2msA%3D%3D
95. CB Harley AB Futcher CW Greider 1990 Telomeres shorten during ageing of human fibroblasts Nature 345 458 460 2342578 1:CAS:528:DyaK3cXksFKntb4%3D
96. D Xu R Neville T Finkel 2000 Homocysteine accelerates endothelial cell senescence FEBS Lett 470 20 24 10722838 1:CAS:528:DC%2BD3cXhslaltrs%3D
97. S Demissie D Levy EJ Benjamin, et al. 2006 Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study Aging Cell 5 325 330 16913878 1:CAS:528:DC%2BD28Xoslait78%3D
98. S Bekaert T De Meyer ER Rietzschel on behalf of the Asklepios investigators, et al. 2007 Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease Aging Cell 6 639 647 17874998 1:CAS:528:DC%2BD2sXhtFeksLbK
99. NJ Samani R Boultby R Butler, et al. 2001 Telomere shortening in atherosclerosis Lancet 358 472 473 11513915 1:CAS:528:DC%2BD3MXmtV2ht7o%3D
100. RM Cawthon KR Smith E O'Brien, et al. 2003 Association between telomere length in blood and mortality in people aged 60 years or older Lancet 361 393 395 12573379 1:CAS:528:DC%2BD3sXptFejuw%3D%3D
101. S Brouilette RK Singh JR Thompson, et al. 2003 White cell telomere length and risk of premature myocardial infarction Arterioscler Thromb Vasc Biol 23 842 846 12649083 1:CAS:528:DC%2BD3sXjtlaktb0%3D
102. SW Brouilette JS Moore AD McMahon for the West of Scotland Coronary Prevention Study Group, et al. 2007 Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study Lancet 369 107 114 17223473 1:CAS:528: DC%2BD2sXltVSrsQ%3D%3D
103. AL Fitzpatrick RA Kronmal JP Gardner, et al. 2007 Leukocyte telomere length and cardiovascular disease in the cardiovascular health study Am J Epidemiol 165 14 21 17043079
104. A Benetos JP Gardner M Zureik, et al. 2004 Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects Hypertension 43 182 185 14732735 1:CAS:528:DC%2BD2cXlvFeiuw%3D%3D
105. P van der Harst G van der Steege RA de Boer, et al. 2007 Telomere length of circulating leukocytes is decreased in patients with chronic heart failure J Am Coll Cardiol 49 1459 1464 17397675
106. J Collerton C Martin-Ruiz A Kenny, et al. 2007 Telomere length is associated with left ventricular function in the oldest old: the Newcastle 85+ study Eur Heart J 28 172 176 17215319 1:CAS:528:DC%2BD2sXjtlKqsb0%3D
107. E Jeanclos A Krolewski J Skurnick, et al. 1998 Shortened telomere length in white blood cells of patients with IDDM Diabetes 47 482 486 9519758 1:CAS:528:DyaK1cXhs1aqurc%3D
108. MJ Sampson MS Winterbone JC Hughes, et al. 2006 Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes Diabetes Care 29 283 289 16443874 1:CAS:528:DC%2BD28Xhs1Kiur4%3D
109. A Benetos K Okuda M Lajemi, et al. 2001 Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity Hypertension 37 381 385 11230304 1:CAS:528: DC%2BD3MXhvVSht70%3D
110. AM Valdes T Andrew JP Gardner, et al. 2005 Obesity, cigarette smoking, and telomere length in women Lancet 366 662 664 16112303 1:CAS:528: DC%2BD2MXosVajsbo%3D
111. LF Cherkas A Aviv AM Valdes, et al. 2006 The effects of social status on biological aging as measured by white-blood-cell telomere length Aging Cell 5 361 365 16856882 1:CAS:528:DC%2BD28XhtFSisbzF
112. RYL Zee SE Michaud S Germer PM Ridker 2009 Association of shorter mean telomere length with risk of incident myocardial infarction: a prospective, nested case-control approach Clin Chim Acta 403 139 141 19217888 1:CAS:528:DC%2BD1MXltFWmsrY%3D
113. NJ Samani PV Harst 2008 Biological aging and cardiovascular disease Heart 94 537 539 18411343 1:CAS:528:DC%2BD1cXmsl2qtr8%3D
114. S Kyo M Takakura T Kanaya, et al. 1999 Estrogen activates telomerase Cancer Res 59 5917 5921 10606235 1:CAS:528:DC%2BD3cXht1SnsQ%3D%3D
115. ES Epel J Lin FH Wilhelm, et al. 2006 Cell aging in relation to stress arousal and cardiovascular disease risk factors PNEC 31 277 287 1:CAS:528:DC%2BD28Xhsl2jtr4%3D
116. M Ogami Y Ikura M Ohsawa, et al. 2004 Telomere shortening in human coronary artery diseases Arterioscler Thromb Vasc Biol 24 546 550 14726417 1:CAS:528:DC%2BD2cXhvFOju70%3D
117. K Okuda MY Khan J Skurnick, et al. 2000 Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis Atherosclerosis 152 391 398 10998467 1:CAS:528:DC%2BD3cXms1WktL4%3D
118. C Matthews I Gorenne S Scott, et al. 2006 Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress Circ Res 99 156 164 16794190 1:CAS:528:DC%2BD28XmvFaltbg%3D
119. C Chimenti J Kajstura D Torella, et al. 2003 Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure Circ Res 93 604 613 12958145 1:CAS:528:DC%2BD3sXnsFSgs7o%3D
120. MJ Davies N Woolf PM Rowles, et al. 1988 Morphology of the endothelium over atherosclerotic plaques in human coronary arteries Br Heart J 60 459 464 3066389 1:STN:280:DyaL1M7jsVGrsw%3D%3D
121. T Minamino H Miyauchi T Yoshida, et al. 2002 Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction Circulation 105 1541 1544 11927518 1:CAS:528:DC%2BD38XjtlCmtLg%3D
122. H Oh SC Wang A Prahash, et al. 2003 Telomere attrition and Chk2 activation in human heart failure Proc Natl Acad Sci USA 100 5378 5383 12702777 1:CAS:528:DC%2BD3sXjs1yitL0%3D
123. A Leri S Franco A Zacheo, et al. 2003 Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation EMBO J 22 131 139 12505991 1:CAS:528:DC%2BD3sXovFartw%3D%3D
124. Q Dai GP Escobar KW Hakala, et al. 2008 The left ventricle proteome differentiates middle-aged and old left ventricles in mice J Proteome Res 7 756 765 18166010 1:CAS:528:DC%2BD1cXitlWitQ%3D%3D
125. OT Njajou WC Hsueh EH Blackburn for the Health ABC Study, et al. 2009 Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study J Gerontol A Biol Sci Med Sci 64A 860 864 1:CAS:528:DC%2BD1MXptVagtbk%3D
126. RA Kerber E O'Brien RM Cawthorn 2009 Gene expression profiles associated with aging and mortality in humans Aging Cell 8 239 250 19245677 1:CAS:528:DC%2BD1MXntFGqurs%3D
127. M Jazwinski S Kim J Dai, et al. 2010 HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging Aging Cell 9 698 708 20569235 1:CAS:528:DC%2BC3cXht1Oju7jF
128. JL Anderson CD Adams EM Antman, et al. 2007 ACC/AHA guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/Non-ST-elevation myocardial infarction) J Am Coll Cardiol 50 652 726
129. TA Pearson SN Blair SR Daniels, et al. 2002 AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases Circulation 106 388 391 12119259
130. SC Smith J Allen SN Blair, et al. 2006 AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute J Am Coll Cardiol 47 2130 2139 16697342
131. Graham I, Atar D, Borch-Johnsen K for the European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG) et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 28:2375-2414
132. DD Schocken EJ Benjamin GC Fonarow, et al. 2008 Prevention of heart failure. A scientific statement from the American Heart Association Councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation 117 2544 2565 18391114
133. GC Fonarow CW Yancy AF Hernandez, et al. 2011 Potential impact of optimal implementation of evidence-based heart failure therapies on mortality Am Heart J 161 1024 1030 21641346
134. DE Forman MW Rich K Alexander, et al. 2011 Cardiac care for older adults. Time for a paradigm J Am Coll Cardiol 57 1801 1810 21527153
135. JB Kostis BR Davis J Cutler, et al. 1997 Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group JAMA 278 212 216 9218667 1:CAS:528:DyaK2sXltFCitrk%3D
136. JA Staessen R Fagard L Thijs, et al. 1997 Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension Lancet 350 757 764 9297994 1:STN:280:DyaK2svktlWgsQ%3D%3D
137. F Gueyffier C Bulpitt JP Boissel for the INDIANA Group, et al. 1999 Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials Lancet 353 793 796 10459960 1:CAS:528: DyaK1MXhvFemsbY%3D
138. DS Budnitz MC Lovegrove N Shehab CL Richards 2011 Emergency hospitalizations for adverse drug events in older Americans New Engl J Med 365 2002 2012 22111719 1:CAS:528:DC%2BC3MXhs1SntLrO
139. LP Svetkey TP Erlinger WM Vollmer, et al. 2005 Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age J Hum Hypertens 19 21 31 15385946 1:STN:280:DC%2BD2cnivFWjuw%3D%3D
140. EP Weiss L Fontana 2011 Caloric restriction: powerful protection for the aging heart and vasculature Am J Physiol Heart Circ Physiol 301 H1205 H1219 21841020 1:CAS:528:DC%2BC3MXhtlersbfM
141. BJ Willcox DC Willcox H Todoriki, et al. 2007 Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span Ann N Y Acad Sci 1114 434 455 17986602 1:CAS:528:DC%2BD2sXhsVKjsr7N
142. C Lenfant 2002 Reflections on hypertension control rates. A message from the Director of the National Heart, Lung, and Blood Institute Arch Int Med 162 131 132
143. J Onysko C Maxwell M Eliasziw, et al. 2006 Large increases in
144. K Tu NRC Campbell M Duong-Hua FA McAlister 2005 Hypertension management in the elderly has improved. Ontario prescribing trends, 1994 to 2002 Hypertension 45 1113 1118 15851629 1:CAS:528:DC%2BD2MXkt1OlsLg%3D
145. OK Andersson T Almgren B Persson, et al. 1998 Survival in treated hypertension: follow-up study after two decades Br Med J 317 167 171 1:STN:280:DyaK1czjt1KlsA%3D%3D
146. G Danaei MM Finucane GM Singh for the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure), et al. 2011 National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants Lancet 377 568 577 21295844
147. P Kaul FA McAlister JA Ezekowitz VK Grover H Quan 2011 Ethnic differences in 1-year mortality among patients hospitalized with heart failure Heart 97 1048 1053 21508417
148. Bleich SN, Herring BJ, Flagg DD et al (2011) Reduction in purchases of sugar-sweetened beverages among low-income black adolescents after exposure to caloric information. Am J Public Health. doi: 10.2105/AJPH.2011.300350